Table 1 Baseline characteristics of the patients
From: Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy
Demographics | M [IQR] or n (%) |
|---|---|
Age, years | 54.78 [23-78] |
Gender | Male 11 (61.1%) |
Female 7 (38.9%) | |
Co-morbidities | |
Obesity | 5 (27.8%) |
Hypertension | 13 (72.2%) |
Chronic cardiac disease | 3 (16.7%) |
Diabetes | 4 (22.2%) |
Risk stratification | |
APACHE II | 11.11 [4-22] |
SOFA | 4.44 [2-14] |
SAPS II | 24.67 [8-45] |
4C ISARIC | 9.06 [4-14] |
Clinical course | |
Need of MV | 13 (76.5%) |
Length of MV (days) | 9 [6-14.75] |
AKI | 7 (41.2%) |
Need of RRT | 6 (35.3%) |
Days of symptoms | 8 [5.5-11] |
Days before ICU | 1 [1-2] |
LOS in ICU (days) | 11 [7-15.25] |
LOS in hospital after ICU (days) | 27.5 [14.5-33.75] |
Mortality | 7 (38.9%) |